Used in pharmaceutical research as a potent inhibitor targeting specific kinases involved in inflammatory and oncogenic signaling pathways. Demonstrates high selectivity in modulating cellular responses related to tumor growth and immune regulation. Investigated for its potential therapeutic role in cancer treatment, particularly in hematological malignancies and solid tumors. Its structure enables strong binding affinity and improved pharmacokinetic properties, making it suitable for oral administration in preclinical models. Also employed in structure-activity relationship (SAR) studies to develop more effective kinase inhibitors.